AI assistant
Lifecare ASA — Director's Dealing 2026
May 19, 2026
3654_rns_2026-05-19_e8c70d7f-8b1f-4218-b7a0-65268fa3f19b.pdf
Director's Dealing
Open in viewerOpens in your device viewer
LIFECARE
PRESS RELEASE
19 May 2026 22:03:00 CEST
LIFECARE ASA: MANDATORY NOTIFICATION OF TRADE
The Company has been informed that Hannibal Invest AS, a company closely associated with Hans Hekland, board member and primary insider of Lifecare ASA, has sold 319,550 shares in the Company at an average price of NOK 0.374 per share. The shares have been sold to finance the exercise of warrants.
Following this transaction, Hannibal Invest AS holds 1,131,948 shares and 705,196 Warrants Series 2 in the Company.
About us
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's focus is to bring the next generation of Continuous Glucose Monitoring systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.
Contacts
For further information, please contact:
Joacim Holter, CEO, [email protected], +47 40 05 90 40
Petter Nielsen, CFO, [email protected], +47 92 24 74 64
This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-05-19 22:03 CEST.
Attachments
260519 PDMR Attachment Hannibal Invest
Lifecare ASA • Ytrebygdsvegen 215 • N-5258 Blomsterdalen